The arachidonic acid (ARA) oil facility will serve global infant formula markets.
"The completion of this new facility will give Cargill the capacity to provide our global infant formula customers with ARA for years to come," said Marcelo Montero, president, Cargill Health and Nutrition.
"The production complex was designed to meet the strict requirements of the international infant formula industry and will give us the flexibility to serve our customers with additional, high-quality capacity as well as the potential for new product lines."
Cargill Alking Bioengineering have been involved in ARA in Chinese and other markets since 2004.